Differences in patient and dermatologist perspectives on psoriasis treatment: results from the UPLIFT survey
Recommended Citation
Reich K, Gisondi P, Stein Gold LF, van de Kerkhof P, Langley R, Paul C, Puig L, Torii H. Differences in patient and dermatologist perspectives on psoriasis treatment: results from the UPLIFT survey. Australas J Dermatol 2022; 63(SUPPL 1):71-72.
Document Type
Conference Proceeding
Publication Date
6-8-2022
Publication Title
Australas J Dermatol
Abstract
Aim: Describe patient and dermatologist perspectives on psoriasis treatment. Methods: Assess patient and physician alignment on determinants of disease severity, treatment priorities and treatment goals using UPLIFT survey respondents top 3 ranked contributing factors for each. Results: 3,806 patients and 473 dermatologists completed the respective UPLIFT surveys; 2,550 patients reported diagnosed psoriasis, without psoriatic arthritis. 56% reported BSA ≤3%. Nearly half of dermatologist practices were community/office-based (Fig.1). Disease burden: Patients top 3 factors defining disease severity were type of symptoms, length of time suffering from psoriasis, and location of skin lesions. Physicians ranked impact on overall QoL, amount of BSA involvement, and type of symptoms as the top 3 factors; disease duration was ranked 10 and lesion location 4. (fig.2). Treatment goals: Reducing itching was the top for patients, then keeping their symptoms controlled and skin clearance. Physicians rated itch reduction as a less important and ranked improving QoL as the most important (fig.2). Patients and physicians thought that their goals were very closely or somewhat closely aligned, there was a moderate to strong need for better therapies. Similar responses regarding top attributes of an ideal psoriasis therapy were observed between patients and physicians, with long-term safety an additional focus for physicians. Patient and physician recall of office visits differed markedly, considerably more patients reporting never discussing things like joint pain, related conditions, and impact of psoriasis on emotional well-being (fig.3).Conclusions: In the 2020 UPLIFT survey, differences between patient and physician perspectives about psoriasis burden and treatment were observed. There was a greater patient focus on specific symptoms of psoriasis, whereas physicians placed greater importance on overall QoL. Recall of past office visits differed between patients and physicians, highlighting an opportunity for patient and physician dialogue to improve with respect to psoriasis treatment and goals of therapy.
Volume
63
Issue
SUPPL 1
First Page
71
Last Page
72
